Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Proinflammatory stimuli, after amyloid β (Aβ) deposition, have been hypothesized to create a self‐reinforcing positive feedback loop that increases amyloidogenic processing of the Aβ precursor protein (APP), promoting further Aβ accumulation and neuroinflammation in Alzheimer's disease (AD). Interleukin‐6 (IL‐6), a proinflammatory cytokine, has been shown to be increased in AD patients implying a pathological interaction. To assess the effects of IL‐6 on Aβ deposition and APP processing in vivo ,we overexpressed murine IL‐6 (mIL‐6) in the brains of APP transgenic TgCRND8 and TG2576 mice. mIL‐6 expression resulted in extensive gliosis and concurrently attenuated Aβ deposition in TgCRND8 mouse brains. This was accompanied by up‐regulation of glial phagocytic markers in vivo and resulted in enhanced microglia‐mediated phagocytosis of Aβ aggregates in vitro . Further, mIL‐6‐induced neuroinflammation had no effect on APP processing in TgCRND8 and had no effect on APP processing or steady‐state levels of Aβ in young Tg2576 mice. These results indicate that mIL‐6‐mediated reactive gliosis may be beneficial early in the disease process by potentially enhancing Aβ plaque clearance rather than mediating a neurotoxic feedback loop that exacerbates amyloid pathology. This is the first study that methodically dissects the contribution of mIL‐6 with regard to its potential role in modulating Aβ deposition in vivo .—Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., Das, P. Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J . 24, 548–559 (2010). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“administration or expression of IFN-γ, TNF or IL-6 in the mouse CNS reduced Aβ deposition [48–50]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [50]
In the citing paper
“For example, increased gliosis induced by brain infusion of lipopolysaccharide (4) or overexpression of the inflammatory cytokine interleukin-6 (5) or interferon-γ (6) markedly reduces amyloid plaque burden.”
From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [5]
In the citing paper
“Strikingly, activation of microglial cells by inflammatory molecules has been shown to enhance Aβ clearance by microglia [3, 26, 27].”
From IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia (2019) · cites this paper as [3]
In the citing paper
“For amyloid pathology, there is data that activated micro/astroglia enhances Aβ phagocytosis [60, 62, 71]”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [71]
In the citing paper
“mice overexpressing IL-6 (127) or IFN-γ (128) had enhanced microglial phagocytosis of Aβ accompanied by an increase in complement component mRNA levels, TNF-α, and other inflammatory mediators.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [127]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 1×
“Since microglia in close apposition to the plaques could display different phenotypes, we decided to further investigate whether mIL-6 overexpression led to the establishment of a neuroprotective alternative M2 glial phenotype, marked by expression of Ym-1 and arginase or whether there was a prevalence of the classica…”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
Ershler, W. B., & Keller, E. T. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.245 · Cited by 1,282
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Cited by
Items 101–200 of 339
Cole, G. M., & Frautschy, S. A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791011991 · Cited by 84
Hopperton, K. E., Trépanier, M.-O., Giuliano, V., & Bazinet, R. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0721-5 · Cited by 78
Modeling Neurodegenerative Microenvironment Using Cortical Organoids Derived from Human Stem Cells
Yan, Y., Song, L., Bejoy, J., Zhao, J., Kanekiyo, T., Bu, G., Zhou, Y., & Li, Y. (2018) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0423 · Cited by 87
Normal cognition in transgenic BRI2-Aβ mice
Kim, J., Chakrabarty, P., Hanna, A., March, A., Dickson, D. W., Borchelt, D. R., Golde, T., & Janus, C. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-15 · Cited by 105
Self-citationPoon, C. T., Shah, K., Lin, C., Tse, R., Kim, K. K., Mooney, S., Aubert, I., Stefanovic, B., & Hynynen, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-32250-3 · Cited by 79
Ayers, J. I., Fromholt, S., Sinyavskaya, O., Siemienski, Z., Rosario, A. M., Li, A., Crosby, K. W., Cruz, P. E., DiNunno, N. M., Janus, C., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2014.180 · Cited by 76
Self-citationTLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer’s disease
Chakrabarty, P., Li, A., Ladd, T. B., Strickland, M. R., Koller, E. J., Burgess, J. D., Funk, C. C., Cruz, P. E., Allen, M., Yaroshenko, M., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20180484 · Cited by 78
Self-citationInterferon-γ induces progressive nigrostriatal degeneration and basal ganglia calcification
Chakrabarty, P., Ceballos-Diaz, C., Lin, W.-L., Beccard, A., Jansen-West, K., McFarland, N. R., Janus, C., Dickson, D., Das, P., & Golde, T. E. (2011) · Nature Neuroscience · doi:10.1038/nn.2829 · Cited by 79
Self-citationMigration of blood cells to β-amyloid plaques in Alzheimer's disease
Hohsfield, L. A., & Humpel, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.002 · Cited by 79
“On the other side, reports indicate that microglial cells are capable of remodeling and enhancing the clearance of Aβ plaques (Chakrabarty et al., 2010; Gate et al., 2010; Kiyota et al., 2009).”
Cortese, G. P., & Bürger, C. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.027 · Cited by 86
Elevated IL-6 and TNF-α Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients
Wu, W., Guan, Y., Zhao, G., Fu, X.-J., Guo, T., Liu, Y., Ren, X., Wang, W., Liu, H.-R., & Li, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9268-1 · Cited by 78
Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Jalouli, M., Rahman, M. A., Jeandet, P., Behl, T., Alexiou, A. T., Albadrani, G. M., Abdel‐Daim, M. M., Perveen, A., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210826130210 · Cited by 81
The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer’s Disease
Azizi, G., Navabi, S. S., Al-Shukaili, A., Seyedzadeh, M. H., Yazdani, R., & Mirshafiey, A. (2015) · Sultan Qaboos University Medical Journal · doi:10.18295/squmj.2015.15.03.002 · Cited by 73
The Brain's Aging Immune System.
Streit, W. J., & Xue, Q. (2010) · PubMed · Cited by 89
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
Azizi, G., & Mirshafiey, A. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.705292 · Cited by 73
Zameer, S., Najmi, A. K., Vohora, D., & Akhtar, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1327200 · Cited by 74
Anita, N. Z., Zebarth, J., Chan, B., Wu, C., Syed, T. W., Shahrul, D., Nguyen, M., Pakosh, M. T., Herrmann, N., Lanctôt, K. L., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.005 · Cited by 84
Defining the Role of Anti- and Pro-inflammatory Outcomes of Interleukin-6 in Mental Health
García‐Juárez, M., & Camacho‐Morales, A. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.03.020 · Cited by 79
Capogna, E., Watne, L. O., Sørensen, Ø., Guichelaar, C. J., Idland, A., Halaas, N. B., Blennow, K., Zetterberg, H., Walhovd, K. B., Fjell, A. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.027 · Cited by 76
Innate Immunity in Alzheimer’s Disease: A Complex Affair
Guillot-Sestier, M.-V., & Town, T. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312050008 · Cited by 72
Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease
Yang, S.-H. (2019) · International Neurourology Journal · doi:10.5213/inj.1938184.092 · Cited by 68
Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
Sun, Z., Zhang, X., So, K.-F., Jiang, W., & Chiu, K. (2024) · Biomolecules · doi:10.3390/biom14070833 · Cited by 71
“On the other hand, the overexpression of the pro-inflammatory factor IL-6 enhanced microglial phagocytic capacity while reducing A β accumulation [131].”
BackgroundRecent Advances in Nanotherapeutics for Neurological Disorders
Vashist, A., Manickam, P., Raymond, A., Yndart, A., Kolishetti, N., Vashist, A., Arias, E., & Nair, M. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00254 · Cited by 77
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 70
Bartolotti, N., & Lazarov, O. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.004 · Cited by 74
Pourbadie, H. G., Sayyah, M., Khoshkholgh-Sima, B., Choopani, S., Nategh, M., Motamedi, F., & Shokrgozar, M. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.020 · Cited by 68
Wagner, L. K., Gilling, K. E., Schormann, E., Kloetzel, P. M., Heppner, F. L., Krüger, E., & Prokop, S. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0453-5 · Cited by 73
Miron, J., Picard, C., Frappier, J., Dea, D., Théroux, L., & Poirier, J. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-171160 · Cited by 65
Ghasemi, M., Roshandel, E., Mohammadian, M., Farhadihosseinabadi, B., Akbarzadehlaleh, P., & Shamsasenjan, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03264-0 · Cited by 74
Wang, H., Yang, F., Xin, R., Cui, D., He, J., Zhang, S., & Sun, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110449 · Cited by 66
Activation of STAT3 Regulates Reactive Astrogliosis and Neuronal Death Induced by AβO Neurotoxicity
Toral-Ríos, D., Patiño‐López, G., Gómez‐Lira, G., Gutiérrez, R., Becerril-Pérez, F., Rosales-Córdova, A., León‐Contreras, J. C., Hernández‐Pando, R., León‐Rivera, I., Soto‐Cruz, I., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207458 · Cited by 72
Levites, Y., Dammer, E. B., Ran, Y., Tsering, W., Duong, D., Abreha, M., Gadhavi, J., Lolo, K., Trejo-Lopez, J., Phillips, J., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101669 · Cited by 56
Self-citationHow to Get from Here to There: Macrophage Recruitment in Alzheimers Disease
Rezai-Zadeh, K., Gate, D., Gowing, G., & Town, T. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256017 · Cited by 64
Daulatzai, M. A. (2016) · Europe PMC (PubMed Central) · Cited by 68
RetractedDissecting Alzheimer's disease pathogenesis in human 2D and 3D models
Cenini, G., Hebisch, M., Iefremova, V., Flitsch, L. J., Breitkreuz, Y., Tanzi, R. E., Kim, D. Y., Peitz, M., & Brüstle, O. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103568 · Cited by 56
Wilcock, D. M., Zhao, Q., Morgan, D., Gordon, M. N., Everhart, A., Wilson, J. G., Lee, J. E., & Colton, C. A. (2011) · ASN Neuro · doi:10.1042/an20110018 · Cited by 58
Inflammatory Risk Factors and Pathologies Associated with Alzheimers Disease
Sastre, M., C. Richardson, J., M. Gentleman, S., & J. Brooks, D. (2011) · Current Alzheimer Research · doi:10.2174/156720511795256062 · Cited by 59
Lee, D. C., Rizer, J., Hunt, J. B., Selenica, M. ‐. B., Gordon, M. N., & Morgan, D. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12002 · Cited by 57
Sporadic Alzheimer disease fibroblasts display an oxidative stress phenotype
Ramamoorthy, M., Sýkora, P., Scheibye‐Knudsen, M., Dunn, C., Kasmer, C., Zhang, Y., Becker, K. G., Croteau, D. L., & Bohr, V. A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.018 · Cited by 58
Hippocampal Transcriptomic Profiles: Subfield Vulnerability to Age and Cognitive Impairment
Ianov, L., Both, M. D. D., Chawla, M. K., Rani, A., Kennedy, A. J., Piras, I. S., Day, J. J., Siniard, A. L., Kumar, A., Sweatt, J. D., et al. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00383 · Cited by 59
Shinohara, M., Petersen, R. C., Dickson, D. W., & Bu, G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1086-9 · Cited by 56
Self-citationKoller, E. J., Brooks, M. M. T., Golde, T. E., Giasson, B. I., & Chakrabarty, P. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0142-z · Cited by 54
Self-citationShamim, D., & Laskowski, M. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517722512 · Cited by 56
AMPA-ergic regulation of amyloid-β levels in an Alzheimer’s disease mouse model
Hettinger, J. C., Lee, H. J., Bu, G., Holtzman, D. M., & Cirrito, J. R. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0256-6 · Cited by 59
Valproic acid enhances microglial phagocytosis of amyloid-beta(1-42).
Smith, A. M., Gibbons, H., & Dragunow, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.041 · Cited by 52
Wostrack, M., Reeb, T., Martin, J., Kehl, V., Shiban, E., Preuß, A., Ringel, F. A., Meyer, B., & Ryang, Y. (2014) · Neurocritical Care · doi:10.1007/s12028-014-9991-x · Cited by 52
Stress and Alzheimer’s disease: A senescence link?
Lyons, C. E., & Bartolomucci, A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.010 · Cited by 56
Impact of the CD40-CD40L Dyad in Alzheimers Disease
Giunta, B. N., Rezai-Zadeh, K. P., & Tan, J. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012099 · Cited by 57
McFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48
“We showed that CNS expression of IFN-γ and IL-6 both reduce Aβ plaques in young APP TgCRND8 mice [25, 26].”
BackgroundResultSelf-citationMicroglia Function in the Normal Brain
Rommy von Bernhardi, M., Heredia, F., Salgado, N., & Muñoz, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_4 · Cited by 55
Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain
Zulfiqar, S., Garg, P., & Nieweg, K. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0140 · Cited by 47
TSPO ligand PK11195 improves Alzheimer-related outcomes in aged female 3xTg-AD mice
Christensen, A., & Pike, C. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.029 · Cited by 40
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Harwardt, T., Lukas, S., Zenger, M., Reitberger, T., Danzer, D., Theresa, Ü., Munday, D. C., Nevels, M. M., & Paulus, C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005748 · Cited by 49
Molecular Bases of Alzheimer’s Disease and Neurodegeneration: The Role of Neuroglia
Luca, A., Calandra, C., & Luca, M. (2018) · Aging and disease · doi:10.14336/ad.2018.0201 · Cited by 39
Targeting innate immunity to protect and cure Alzheimer’s disease: opportunities and pitfalls
Cisbani, G., & Rivest, S. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01083-4 · Cited by 46
TIMP-1 Attenuates Blood–Brain Barrier Permeability in Mice with Acute Liver Failure
Chen, F., Radisky, E. S., Das, P., Batra, J., Hata, T., Hori, T., Baine, A.-M. T., Gardner, L. B., Yue, M., Bu, G., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.45 · Cited by 46
Self-citationIFN‐γ promotes τ phosphorylation without affecting mature tangles
Li, A., Ceballos‐Diaz, C., DiNunno, N., Levites, Y., Cruz, P. E., Lewis, J., Golde, T. E., & Chakrabarty, P. (2015) · The FASEB Journal · doi:10.1096/fj.15-275834 · Cited by 43
“Some preclinical studies suggest that inflammatory signaling directly contributes to Ab pathogenesis (38, 39), whereas other studies suggest that innate immune activation may be beneficial (40, 41).”
BackgroundSelf-citationStatins: The Role in the Treatment and Prevention of Alzheimer's Neurodegeneration
Pac-Soo, C., Lloyd, D. G., Vizcaychipi, M. P., & Ma, D. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110524 · Cited by 46
Escrig, A., Canal, C., Sanchís, P., Fernández‐Gayol, O., Montilla, A., Comes, G., Molinero, A., Giralt, M., Giménez‐Llort, L., Becker‐Pauly, C., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.08.005 · Cited by 44
Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice
Jiao, Y.-N., Zhang, J., Wen-jun, Q., Tian, S.-Y., Wang, Y.-B., Wang, C., Zhang, Y., Zhang, Q., Li, W., Min, D., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02626-0 · Cited by 44
Alteration of the Cerebral Zinc Pool in a Mouse Model of Alzheimer Disease
Lee, J.-Y., Cho, E., Seo, J.-W., Hwang, J. J., & Koh, J.-Y. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182417387 · Cited by 42
Baerends, E. A. M., Soud, K., Folke, J., Pedersen, A.-K., Henmar, S., Konrad, L., Lycas, M. D., Mori, Y., Pakkenberg, B., Woldbye, D. P. D., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01417-5 · Cited by 44
Huang, H., Zhang, Z., & Wu, H. (2016) · Pharmacognosy Magazine · doi:10.4103/0973-1296.182174 · Cited by 43
Colon-Perez, L. M., Ibanez, K. R., Suarez, M., Torroella, K., Acuna, K., Ofori, E., Levites, Y., Vaillancourt, D. E., Golde, T. E., Chakrabarty, P., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116138 · Cited by 41
“IL6 expression results in widespread gliosis in the CNS in the absence of overt amyloidogenic or neurodegenerative pathology (Chakrabarty et al., 2010b), and was thus considered ideal for testing the individual or combined effects of Aβ and neuroinflammation on in vivo tissue microstructure in…”
BackgroundMethodResultInfluentialSelf-citationInterleukin-6 deficiency exacerbates Huntington’s disease model phenotypes
Wertz, M. H., Pineda, S. S., Lee, H., Kulicke, R., Kellis, M., & Heiman, M. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00379-3 · Cited by 43
β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes
Robinson, K. F., Narasipura, S. D., Wallace, J., Ritz, E. M., & Al‐Harthi, L. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00565-2 · Cited by 45
Hoshino, T., Namba, T., Takehara, M., Murao, N., Matsushima, T., Sugimoto, Y., Narumiya, S., Suzuki, T., & Mizushima, T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07567.x · Cited by 41
Wijesinghe, P., Whitmore, C. A., Campbell, M., Li, C. H., Tsuyuki, M., To, E. C., Haynes, J. R., Pham, W. N., & Matsubara, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1107436 · Cited by 41
Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease
Golde, T. E., Streit, W. J., & Chakrabarty, P. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt178 · Cited by 38
Self-citationWang, J., Lei, X., Xie, Z., Zhang, X., Cheng, X., Zhou, W., & Zhang, Y. (2019) · Aging · doi:10.18632/aging.101990 · Cited by 39
Galantamine attenuates amyloid-β deposition and astrocyte activation in APP/PS1 transgenic mice
Wu, Z., Zhao, L., Chen, X., Cheng, X., & Zhang, Y. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.10.015 · Cited by 39
Dendritic Polyglycerol Sulfates in the Prevention of Synaptic Loss and Mechanism of Action on Glia
Maysinger, D., Ji, J. X., Moquin, A., Hossain, S., Hancock, M. A., Zhang, I., Chang, P. K. ‐., Rigby, M., Anthonisen, M., Grütter, P., et al. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00301 · Cited by 39
Albrecht, D. S., Sagare, A., Pachicano, M., Sweeney, M. D., Toga, A., Zlokovic, B., Chui, H., Joe, E., Schneider, L., Morris, J. C., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.01.010 · Cited by 37
“Our result suggesting IL-6 may be protective against increased Aβ levels in cognitive normal older adults is consistent with evidence that IL-6 suppresses amyloid deposition in an AD mouse model (Chakrabarty et al., 2010).”
ResultAnimal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective
Banerjee, R., Rai, A., Iyer, S., Narwal, S., & Tare, M. (2022) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12209 · Cited by 37
Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype
Lane, R. M., & He, Y. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.005 · Cited by 39
Ohno, M., Hiraoka, Y., Lichtenthaler, S. F., Nishi, K., Saijo, S., Matsuoka, T., Tomimoto, H., Araki, W., Takahashi, R., Kita, T., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.014 · Cited by 38
Das, P., Verbeeck, C., Minter, L., Chakrabarty, P., Felsenstein, K., Kukar, T., Maharvi, G., Fauq, A., Osborne, B. A., & Golde, T. E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-39 · Cited by 35
Self-citationLuo, Q., Schnöder, L., Hao, W., Litzenburger, K., Decker, Y., Tomic, I., Menger, M. D., Fassbender, K. C., & Liu, Y. (2022) · Aging Cell · doi:10.1111/acel.13679 · Cited by 36
Rutherford, N. J., Sacino, A. N., Brooks, M., Ceballos-Diaz, C., Ladd, T. B., Howard, J. K., Golde, T. E., & Giasson, B. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0029-4 · Cited by 35
Self-citationRivera-Escalera, F., Matousek, S. B., Ghosh, S., Olschowka, J. A., & O’Banion, M. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.018 · Cited by 34
West Nile Virus-Induced Neurologic Sequelae—Relationship to Neurodegenerative Cascades and Dementias
Vittor, A. Y., Long, M. T., Chakrabarty, P., Aycock, L., Kollu, V., & DeKosky, S. T. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00200-7 · Cited by 36
Self-citationExpression of endogenous mouse APP modulates β-amyloid deposition in hAPP-transgenic mice
Steffen, J., Krohn, M., Schwitlick, C., Brüning, T., Paarmann, K., Pietrzik, C. U., Biverstål, H., Jansone, B., Langer, O., & Pahnke, J. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0448-2 · Cited by 31
Microglia activation is essential for BMP7-mediated retinal reactive gliosis
Dharmarajan, S., Fisk, D. L., Sorenson, C. M., Sheibani, N., & Belecky‐Adams, T. L. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0855-0 · Cited by 33
Inflammation in Alzheimer’s Disease: Do Sex and APOE Matter?
Duarte‐Guterman, P., Initiative, O. B. O. T. A. D. N., Albert, A., Inkster, A. M., Barha, C. K., & Galea, L. A. M. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200982 · Cited by 33
Regulation of cyclic AMP response element‐binding protein during neuroglial interactions
Qin, L., Bouchard, R. J., & Pugazhenthi, S. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13497 · Cited by 32
Angel, A., Volkman, R., Royal, T. G., & Offen, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031144 · Cited by 33
Xu, G. M., Fromholt, S., Chakrabarty, P., Zhu, F., Liu, X., Pace, M. C., Koh, J., Golde, T. E., Levites, Y., Lewis, J. M., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00911-y · Cited by 32
Self-citationCarrano, A., & Das, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140210 · Cited by 31
Self-citationLi, B., Gao, Y., Zhang, W., & Xu, J. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24187 · Cited by 30
The Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model
Lloyd, G. M., Dhillon, J.-K. S., Gorion, K.-M. M., Riffe, C. J., Fromholt, S., Xia, Y., Giasson, B. I., & Borchelt, D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00486-9 · Cited by 31
Daniilidou, M., Holleman, J., Hagman, G., Kåreholt, I., Aspö, M., Brinkmalm, A., Zetterberg, H., Blennow, K., Solomon, A., Kivipelto, M., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03072-x · Cited by 28
Doroszkiewicz, J., Winkel, I., & Mroczko, B. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1579511 · Cited by 30
Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
Kakkar, A., Singh, H., Singh, B. K., Kumar, A., Mishra, A. K., & Chopra, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374353 · Cited by 30
Guilherme, M. D. S., Stoye, N. M., Rose‐John, S., Garbers, C., Fellgiebel, A., & Endres, K. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00182 · Cited by 29
Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
Raikwar, S. P., Thangavel, R., Dubova, I., Ahmed, M. E., Selvakumar, G. P., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180422 · Cited by 32
Panayiotou, E., Fella, E., Andreou, S., Papacharalambous, R., Gerasimou, P., Costeas, P., Angeli, S., Kousiappa, I., Papacostas, S., & Kyriakides, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225417 · Cited by 30
Remodeling Alzheimer-amyloidosis models by seeding
Ulm, B. S., Borchelt, D., & Moore, B. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00429-4 · Cited by 30
Metadata
- Authors
- Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P.
- Affiliations
- Mayo Clinic in Florida (US)
- Corresponding author
- Das, Pritam
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-10-13
- Volume
- 24
- Issue
- 2
- Pages
- 548-559
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3083918
- OpenAlex
- W1977896329
- Cited by
- 328
- References
- 50
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 19 · 2023: 13 · 2022: 34 · 2021: 21 · 2020: 26 · 2019: 23 · 2018: 23 · 2017: 23 · 2016: 19 · 2015: 20 · 2014: 16 · 2013: 19 · 2012: 21
- FWCI
- 11.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Clinic
- American Health Assistance Foundation (AHAF3J)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- interleukin-6, reactive gliosis, amyloid-beta deposition, Alzheimer's disease, neuroinflammation, APP processing, microglial phagocytosis, TgCRND8 mice, Tg2576 mice, amyloid plaque clearance
- MeSH terms
- Alzheimer Disease, Animals, Gliosis, Humans, Inflammation, Mice, Transgenic, Phagocytosis, Interleukin-6, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.